Free Trial

Trupanion (NASDAQ:TRUP) Price Target Raised to $45.00

Trupanion logo with Finance background

Key Points

  • Investment analysts at Stifel Nicolaus raised Trupanion's price target to $45.00, indicating a potential downside of 10.67% from its previous close.
  • Trupanion's stock recently saw a 3.3% increase in value, trading at $50.38 during Friday's sessions.
  • The company reported quarterly earnings of $0.22 per share, outperforming consensus estimates and showing a 12.3% year-over-year revenue increase.
  • Need Better Tools to Track Trupanion? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Trupanion (NASDAQ:TRUP - Get Free Report) had its price target increased by investment analysts at Stifel Nicolaus from $41.00 to $45.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a "hold" rating on the financial services provider's stock. Stifel Nicolaus' price target would indicate a potential downside of 10.67% from the stock's previous close.

A number of other research firms have also recently issued reports on TRUP. Lake Street Capital cut their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Piper Sandler boosted their target price on shares of Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a research note on Friday. Two analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $55.60.

View Our Latest Stock Report on TRUP

Trupanion Stock Up 3.3%

NASDAQ:TRUP traded up $1.63 during trading hours on Friday, hitting $50.38. The stock had a trading volume of 740,265 shares, compared to its average volume of 601,517. The company has a market cap of $2.16 billion, a PE ratio of -500.70 and a beta of 1.78. The business has a 50 day simple moving average of $51.08 and a two-hundred day simple moving average of $44.01. Trupanion has a 1-year low of $31.00 and a 1-year high of $57.90. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.38.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of ($0.03) by $0.25. The firm had revenue of $353.56 million during the quarter, compared to analyst estimates of $346.73 million. Trupanion had a negative return on equity of 1.33% and a negative net margin of 0.32%. Trupanion's quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.14) EPS. Analysts predict that Trupanion will post 0.13 EPS for the current year.

Insider Buying and Selling at Trupanion

In other news, CEO Margaret Tooth sold 4,000 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total value of $183,440.00. Following the sale, the chief executive officer directly owned 118,784 shares of the company's stock, valued at approximately $5,447,434.24. This trade represents a 3.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO John R. Gallagher sold 4,000 shares of the firm's stock in a transaction on Thursday, May 29th. The stock was sold at an average price of $47.90, for a total transaction of $191,600.00. Following the completion of the sale, the chief operating officer owned 26,966 shares in the company, valued at approximately $1,291,671.40. The trade was a 12.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,562 shares of company stock worth $544,870 over the last 90 days. Insiders own 5.42% of the company's stock.

Institutional Investors Weigh In On Trupanion

Institutional investors have recently added to or reduced their stakes in the stock. Maryland State Retirement & Pension System lifted its stake in shares of Trupanion by 2.1% during the second quarter. Maryland State Retirement & Pension System now owns 9,933 shares of the financial services provider's stock valued at $550,000 after acquiring an additional 201 shares during the period. Yousif Capital Management LLC lifted its position in Trupanion by 1.8% during the 2nd quarter. Yousif Capital Management LLC now owns 12,580 shares of the financial services provider's stock valued at $696,000 after purchasing an additional 226 shares during the period. PNC Financial Services Group Inc. boosted its stake in shares of Trupanion by 11.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,234 shares of the financial services provider's stock valued at $83,000 after purchasing an additional 235 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Trupanion by 3.5% in the 2nd quarter. Bank of Montreal Can now owns 7,280 shares of the financial services provider's stock valued at $403,000 after purchasing an additional 245 shares during the last quarter. Finally, Nisa Investment Advisors LLC grew its position in shares of Trupanion by 44.1% during the 2nd quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider's stock worth $54,000 after buying an additional 300 shares during the period.

About Trupanion

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines